Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Covalon Technologies Ltd (CVALF)

Covalon Technologies Ltd (CVALF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Covalon Technologies Ltd 1660 Tech Avenue Unit 5 Mississauga A6 L4W 5S7 CAN

www.covalon.com P: 905-568-8400

Sector:

Medical

INDUSTRY GROUPING:

Medical Instruments

Description:

Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies. The company's patented technologies, product and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Its technologies are used to prevent, detect and manage medical conditions in specialty areas such as infection control, vascular access, surgical procedures, advanced wound care and medical device coatings. Covalon Technologies Ltd. is based in Mississauga, Canada.

Key Statistics

Overview:

Market Capitalization, $K 33,970
Enterprise Value, $K 21,550
Shares Outstanding, K 27,618
Float, K 27,618
% Float 100.00%
Short Interest, K 10
Short Float 0.04%
Days to Cover 1.00
Short Volume Ratio 1.00
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 23,460 K
Annual Net Income, $ 1,470 K
Last Quarter Sales, $ 6,290 K
Last Quarter Net Income, $ 260 K
EBIT, $ 1,260 K
EBITDA, $ 1,940 K

Growth:

1-Year Return -42.25%
3-Year Return -22.15%
5-Year Return 29.47%
5-Year Revenue Growth 22.19%
5-Year Earnings Growth 125.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.01 on 12/11/25
Next Earnings Date 02/20/26 [--]
Earnings Per Share ttm 0.05
EPS Growth vs. Prev Year 0.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 07/23/13

CVALF Ratios

Ratio
Price/Earnings ttm 24.40
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 6.75%
Return-on-Assets % 5.83%
Profit Margin % 6.27%
Debt/Equity 0.00
Price/Sales 1.44
Price/Cash Flow 15.66
Price/Book 1.54
Book Value/Share 0.80
Interest Coverage -1.14
60-Month Beta 0.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar